DK2001445T3 - Farmaceutiske sfæroider - Google Patents

Farmaceutiske sfæroider

Info

Publication number
DK2001445T3
DK2001445T3 DK07733554.5T DK07733554T DK2001445T3 DK 2001445 T3 DK2001445 T3 DK 2001445T3 DK 07733554 T DK07733554 T DK 07733554T DK 2001445 T3 DK2001445 T3 DK 2001445T3
Authority
DK
Denmark
Prior art keywords
spheroids
pharmaceutical
pharmaceutical spheroids
Prior art date
Application number
DK07733554.5T
Other languages
English (en)
Inventor
Helen Kathleen Danagher
Geoffrey Gerard Hayes
Hassan Mohammad
Malcolm Walden
Jonathon Oliver Whitehouse
Original Assignee
Euro Celtique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0605271A external-priority patent/GB0605271D0/en
Priority claimed from GB0605542A external-priority patent/GB0605542D0/en
Priority claimed from GB0617272A external-priority patent/GB0617272D0/en
Application filed by Euro Celtique filed Critical Euro Celtique
Application granted granted Critical
Publication of DK2001445T3 publication Critical patent/DK2001445T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK07733554.5T 2006-03-16 2007-03-16 Farmaceutiske sfæroider DK2001445T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0605271A GB0605271D0 (en) 2006-03-16 2006-03-16 Pharmaceutical spheroids
GB0605542A GB0605542D0 (en) 2006-03-20 2006-03-20 Pharmaceutical Spheroids
GB0617272A GB0617272D0 (en) 2006-09-04 2006-09-04 Pharmaceutical spheroids
PCT/GB2007/050129 WO2007105016A1 (en) 2006-03-16 2007-03-16 Pharmaceutical spheroids

Publications (1)

Publication Number Publication Date
DK2001445T3 true DK2001445T3 (da) 2014-10-27

Family

ID=38191129

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07733554.5T DK2001445T3 (da) 2006-03-16 2007-03-16 Farmaceutiske sfæroider

Country Status (13)

Country Link
US (1) US9034373B2 (da)
EP (1) EP2001445B1 (da)
JP (2) JP5443768B2 (da)
CY (1) CY1115770T1 (da)
DK (1) DK2001445T3 (da)
ES (1) ES2516693T3 (da)
HR (1) HRP20141001T1 (da)
ME (1) ME02135B (da)
PL (1) PL2001445T3 (da)
PT (1) PT2001445E (da)
RS (1) RS53624B1 (da)
SI (1) SI2001445T1 (da)
WO (1) WO2007105016A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2001445B1 (en) * 2006-03-16 2014-07-23 Euro-Celtique S.A. Pharmaceutical spheroids
AT511581A1 (de) 2011-05-26 2012-12-15 G L Pharma Gmbh Orale retardierende formulierung
FR3080278B1 (fr) * 2018-04-11 2021-04-30 Ghs Patents Ltd Procede de fabrication d'un spheroide de cannabidiol

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471784A1 (fr) 1979-12-21 1981-06-26 Roussel Uclaf Medicaments antiarythmiques a action prolongee dont le principe actif est le a/2-/bis (1-methylethyl) amino/ethyl/-a-phenyl-2-pyridine acetamide ou ses sels, ainsi que le procede de preparation de ces nouveaux medicaments et compositions les renfermant
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
SE9200858L (sv) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Metod för framställning av pellets med fördröjd frisättning
EP0654263B1 (en) 1993-11-23 2002-01-23 Euro-Celtique S.A. Method for preparing a sustained release composition
DE4415921A1 (de) 1994-05-05 1995-11-09 Bayerische Motoren Werke Ag Vorrichtung zum Dämpfen von Schwingungen in einer Getriebeschaltvorrichtung für Fahrzeuge
EP0762869A1 (en) 1994-06-03 1997-03-19 The Procter & Gamble Company Fast dissolving dosage forms
US5458823A (en) 1994-10-28 1995-10-17 Fuisz Technologies Ltd. Method and apparatus for spinning feedstock material
ATE251896T1 (de) * 1994-12-19 2003-11-15 Daiichi Seiyaku Co Granulat-präparate mit kontinuierlicher freisetzung und verfahren zur herstellung
US5972373A (en) * 1995-05-02 1999-10-26 Taisho Pharmaceutical Co., Ltd. Taste masking pharmaceutical composition for oral administration
ATE283038T1 (de) 1995-07-21 2004-12-15 Daiichi Seiyaku Co Verfahren zu herstellung einer granulären zubereitung
JP5042447B2 (ja) * 1995-07-21 2012-10-03 第一三共株式会社 混合製剤
US5851454A (en) 1997-06-13 1998-12-22 Fuisz Technologies, Ltd. Spinner head having flow restricting inserts
RS49982B (sr) 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
US6117452A (en) 1998-08-12 2000-09-12 Fuisz Technologies Ltd. Fatty ester combinations
EP2275141A1 (en) * 1999-03-17 2011-01-19 Daiichi Pharmaceutical Co., Ltd. Tastemasked pharmaceutical compositions
US6419954B1 (en) * 2000-05-19 2002-07-16 Yamanouchi Pharmaceutical Co., Ltd. Tablets and methods for modified release of hydrophilic and other active agents
WO2002064121A1 (en) * 2001-02-13 2002-08-22 Astrazeneca Ab Novel modified released formulation
CN100500130C (zh) 2003-01-23 2009-06-17 株式会社太平洋 缓释制剂及其制备方法
WO2004100883A2 (en) * 2003-05-06 2004-11-25 Bpsi Holdings, Inc. Method for preparing thermoformed compositions containing acrylic polymer binders, pharmaceutual dosage forms and methods of preparing the same
EP2001445B1 (en) * 2006-03-16 2014-07-23 Euro-Celtique S.A. Pharmaceutical spheroids

Also Published As

Publication number Publication date
HRP20141001T1 (hr) 2014-12-05
PT2001445E (pt) 2014-10-24
CY1115770T1 (el) 2017-01-25
EP2001445A1 (en) 2008-12-17
JP2014088363A (ja) 2014-05-15
US9034373B2 (en) 2015-05-19
JP5443768B2 (ja) 2014-03-19
WO2007105016A1 (en) 2007-09-20
ES2516693T3 (es) 2014-10-31
RS53624B1 (en) 2015-04-30
EP2001445B1 (en) 2014-07-23
PL2001445T3 (pl) 2015-06-30
SI2001445T1 (sl) 2015-02-27
US20100047337A1 (en) 2010-02-25
ME02135B (me) 2015-04-30
JP2009530258A (ja) 2009-08-27

Similar Documents

Publication Publication Date Title
LTC2140867I2 (lt) Farmacinė kompozicija
DK2041139T3 (da) Farmaceutiske forbindelser
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
DK2399580T3 (da) Farmaceutiske doseringsformer
BRPI0715712A2 (pt) Composição farmacêutica
DK1986650T3 (da) Manipulationssikre doserignsformer
BRPI0920521A2 (pt) combinação farmacêutica
ATE450271T1 (de) Impfstoff
BRPI0719393A2 (pt) Composição farmacêutica
DE602007013937D1 (de) Torantagonisten
BRPI0721651A2 (pt) Composição farmacêutica
DE602007012130D1 (de) Modifizierte flavin-adenin-dinucleotid-abhängige glucose-dehydrogenase
FI20060389L (fi) Sensori
DE602007008400D1 (de) Kaliummonopersulfatlösungen
BRPI0716445A2 (pt) composiÇço farmacÊutica
BRPI0717939A2 (pt) Aminometil-4-imidazóis
DE502007000218D1 (de) nsetzungen
BRPI0720234A2 (pt) Composição farmacêutica
DK2120884T3 (da) Farmaceutisk sammensætning
BRPI0719394A2 (pt) Preparação medicinal sólida
DK2271618T3 (da) Farmaceutiske forbindelser
DE102006045567A8 (de) Crimpstabilisierung
DE112007003147A5 (de) Rohr-Biegevorrichtung
BRPI0719956A2 (pt) Radiofluoração
DE112007001125A5 (de) Käfigmutter